Patient characteristics (N = 180)
| Variable . | Median (range) . | No. (%) . |
|---|---|---|
| Sex | ||
| Male | — | 116 (64) |
| Female | — | 64 (36) |
| Rai stage | ||
| 0 | — | 32 (17.8) |
| I | — | 51 (28.3) |
| II | — | 30 (16.7) |
| III | — | 15 (8.3) |
| IV | — | 45 (25.0) |
| Age, y | 61 (33-84) | — |
| CD38+/CD19+, % | 7.7 (0.3-98) | — |
| Hemoglobin level, g/dL | 12.8 (4-17.8) | — |
| Platelet count, × 103/μL | 142 (4-342) | — |
| White blood cell count, × 103/μL | 55.9 (1.4-333.9) | — |
| Lymphocyte count, % | 85 (9-99) | — |
| β2-microglobulin level, mg/L | 3.4 (1.3-12.7) | — |
| cCD20, nM/L | 776.9 (52.89-15 740) | — |
| Variable . | Median (range) . | No. (%) . |
|---|---|---|
| Sex | ||
| Male | — | 116 (64) |
| Female | — | 64 (36) |
| Rai stage | ||
| 0 | — | 32 (17.8) |
| I | — | 51 (28.3) |
| II | — | 30 (16.7) |
| III | — | 15 (8.3) |
| IV | — | 45 (25.0) |
| Age, y | 61 (33-84) | — |
| CD38+/CD19+, % | 7.7 (0.3-98) | — |
| Hemoglobin level, g/dL | 12.8 (4-17.8) | — |
| Platelet count, × 103/μL | 142 (4-342) | — |
| White blood cell count, × 103/μL | 55.9 (1.4-333.9) | — |
| Lymphocyte count, % | 85 (9-99) | — |
| β2-microglobulin level, mg/L | 3.4 (1.3-12.7) | — |
| cCD20, nM/L | 776.9 (52.89-15 740) | — |